Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
emil.vergara@paediatrics.ox.ac.uk

Research groups

Oxford Vaccine Group

Emil Vergara

Postdoctoral Researcher

Recent publications

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity.

Vergara EJ. et al, (2024), NPJ Vaccines, 9

Marked enhancement of the immunogenicity of plant-expressed IgG-Fc fusion proteins by inclusion of cholera toxin non-toxic B subunit within the single polypeptide.

Kim M-Y. et al, (2024), Plant Biotechnol J, 22, 1402 - 1416

Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionality.

Uetz P. et al, (2024), Front Bioeng Biotechnol, 12

Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection.

Bellini C. et al, (2023), Bioconjug Chem, 34, 1738 - 1753

Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity.

Vergara EJ. et al, (2023), Front Immunol, 14

More publications